These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 27072825)

  • 1. Shorter telomeres and high telomerase activity correlate with a highly aggressive phenotype in breast cancer cell lines.
    Ceja-Rangel HA; Sánchez-Suárez P; Castellanos-Juárez E; Peñaroja-Flores R; Arenas-Aranda DJ; Gariglio P; Benítez-Bribiesca L
    Tumour Biol; 2016 Sep; 37(9):11917-11926. PubMed ID: 27072825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53-Dependent accelerated senescence induced by ionizing radiation in breast tumour cells.
    Jones KR; Elmore LW; Jackson-Cook C; Demasters G; Povirk LF; Holt SE; Gewirtz DA
    Int J Radiat Biol; 2005 Jun; 81(6):445-58. PubMed ID: 16308915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity-Senescence-Breast Cancer: Clinical Presentation of a Common Unfortunate Cycle.
    Engin AB; Engin A
    Adv Exp Med Biol; 2024; 1460():821-850. PubMed ID: 39287873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.
    Brachner A; Sasgary S; Pirker C; Rodgarkia C; Mikula M; Mikulits W; Bergmeister H; Setinek U; Wieser M; Chin SF; Caldas C; Micksche M; Cerni C; Berger W
    Cancer Res; 2006 Apr; 66(7):3584-92. PubMed ID: 16585183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mild hyperoxia limits hTR levels, telomerase activity, and telomere length maintenance in hTERT-transduced bone marrow endothelial cells.
    Napier CE; Veas LA; Kan CY; Taylor LM; Yuan J; Wen VW; James A; O'Brien TA; Lock RB; MacKenzie KL
    Biochim Biophys Acta; 2010 Oct; 1803(10):1142-53. PubMed ID: 20619302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-beta receptor mediated telomerase inhibition, telomere shortening and breast cancer cell senescence.
    Cassar L; Nicholls C; Pinto AR; Chen R; Wang L; Li H; Liu JP
    Protein Cell; 2017 Jan; 8(1):39-54. PubMed ID: 27696331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of retinoblastoma in the absence of telomerase activity.
    Gupta J; Han LP; Wang P; Gallie BL; Bacchetti S
    J Natl Cancer Inst; 1996 Aug; 88(16):1152-7. PubMed ID: 8757195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine accelerates senescence of endothelial cells via DNA hypomethylation of human telomerase reverse transcriptase.
    Zhang D; Sun X; Liu J; Xie X; Cui W; Zhu Y
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):71-8. PubMed ID: 25359865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of telomerase activity by dominant-negative hTERT retards the growth of breast cancer cells.
    Rao Y; Xiong W; Liu H; Jia C; Zhang H; Cui Z; Zhang Y; Cui J
    Breast Cancer; 2016 Mar; 23(2):216-23. PubMed ID: 25098685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone morphogenetic protein-7 induces telomerase inhibition, telomere shortening, breast cancer cell senescence, and death via Smad3.
    Cassar L; Nicholls C; Pinto AR; Li H; Liu JP
    FASEB J; 2009 Jun; 23(6):1880-92. PubMed ID: 19193721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex roles for telomeres and telomerase in breast carcinogenesis.
    Artandi SE
    Breast Cancer Res; 2003; 5(1):37-41. PubMed ID: 12559044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A human breast cancer model for the study of telomerase inhibitors based on a new biotinylated-primer extension assay.
    Raymond E; Sun D; Izbicka E; Mangold G; Silvas E; Windle B; Sharma S; Soda H; Laurence R; Davidson K; Von Hoff DD
    Br J Cancer; 1999 Jul; 80(9):1332-41. PubMed ID: 10424733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lentiviral vector mediated siRNA knock-down of hTERT results in diminished capacity in invasiveness and in vivo growth of human glioma cells in a telomere length-independent manner.
    Zhao P; Wang C; Fu Z; You Y; Cheng Y; Lu X; Lu A; Liu N; Pu P; Kang C; Salford LG; Fan X
    Int J Oncol; 2007 Aug; 31(2):361-8. PubMed ID: 17611693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human telomerase reverse transcriptase regulates MMP expression independently of telomerase activity via NF-κB-dependent transcription.
    Ding D; Xi P; Zhou J; Wang M; Cong YS
    FASEB J; 2013 Nov; 27(11):4375-83. PubMed ID: 23884427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells.
    Chen R; Zhu J; Dong Y; He C; Hu X
    Oncotarget; 2015 Oct; 6(32):32841-55. PubMed ID: 26418880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MST-312 Alters Telomere Dynamics, Gene Expression Profiles and Growth in Human Breast Cancer Cells.
    Gurung RL; Lim SN; Low GK; Hande MP
    J Nutrigenet Nutrigenomics; 2014; 7(4-6):283-98. PubMed ID: 26022559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells.
    Perrem K; Colgin LM; Neumann AA; Yeager TR; Reddel RR
    Mol Cell Biol; 2001 Jun; 21(12):3862-75. PubMed ID: 11359895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomere dynamics in cells with introduced telomerase: a rapid assay for telomerase activity on telomeres.
    McChesney PA; Aisner DL; Frank BC; Wright WE; Shay JW
    Mol Cell Biol Res Commun; 2000 May; 3(5):312-8. PubMed ID: 10964756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomere shortening in breast cancer cells (MCF7) under treatment with low doses of the benzylisoquinoline alkaloid chelidonine.
    Kazemi Noureini S; Fatemi L; Wink M
    PLoS One; 2018; 13(10):e0204901. PubMed ID: 30281650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase activity and telomere length in human tumor cells with acquired resistance to anticancer agents.
    Smith V; Dai F; Spitz M; Peters GJ; Fiebig HH; Hussain A; Burger AM
    J Chemother; 2009 Nov; 21(5):542-9. PubMed ID: 19933046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.